Hira KHALID, Muhammad Arif LODHI, Almas SATTAR, Aziz UR REHMAN, Muhammad Athar ABBASI, Sabahat Zahra SIDDIQUI, Shahid RASOOL, Farman Ali KHAN

Synthesis, biological evaluation, and in silico study of some unique multifunctional 1,2,4-triazole acetamides

The imperative demand for antibacterial agents and enzyme inhibitors prompted us to synthesize some new compounds, 6a–6k, bearing multifunctional moieties. The target acetamides were derived from 4-phenyl-5-(1- tosylpiperidin-4-yl)-4H -1,2,4-triazole-3-thiol (3). The structural analysis was carried out using modern spectroscopic techniques including IR, NMR, and EIMS spectral analysis. The antibacterial activity was screened against five bacterial strains including three gram-negative and two gram-positive ones. Enzyme inhibition was carried out against lipoxygenase enzyme and results were supported by in silico study. The synthesized compounds were proved to be potent antibacterial agents and enzyme inhibitors.

PDF

___

1. Golkar, Z.; Bagazra, O.; Pace, D. G. J. Infect. Dev. Ctries. 2014, 8, 129-136.
2. Wright, G. D. Can. J. Microbiol. 2014, 60, 147-154.
3. Lee-Do, K.; Hwang, J. U.; Baek, E. H.; Lee, K. O.; Kim, K. J.; Ha, N. J. Arch. Pharm. Res. 2008, 31, 1016-1022.
4. Yla-Herttuala, S.; Rosenfeld, M. E.; Parthasarathy, S.; Sigal, E.; Sarkioja, T.; Witztum, J. L.; Steinberg, D. J. Clin. Investig. 1991, 87, 1146-1152.
5. Serhan, C. N. Am. J. Pathol. 2010, 177, 1576-1591.
6. Jupp, J.; Hillier, K.; Elliott, D. H.; Fine, D. R.; Bateman, A. C.; Johnson, P. A.; Cazaly, A. M.; Penrose, J. F.; Sampson, A. P. Inflamm. Bowel Dis. 2007, 13, 537-546.
7. Wang, D.; Dubois, R. N. Nat. Rev. Cancer. 2010, 10, 181-193.
8. Priya, B. S.; Swamy, B. S. N.; Rangapa, K. S. Bioorg. Med. Chem. 2005, 13, 2623-2628.
9. Joullie, M. M.; Lassen, K. M. Arkivoc 2010, 8, 189-250.
10. Zhao, Y.; Wang, W.; Wang, Q.; Zhang, X.; Ye, L. Biochem. Biophys. Res. Commun. 2012, 418, 647-651.
11. Kerjaschki, D.; Bago-Horvath, Z.; Rudas, M.; Sexl, V.; Schneckenleithner, C.; Wolbank, S.; Bartel, G.; Krieger, S.; Kalt, R.; Hantusch, B. et al. J. Clin. Investig. 2011, 121, 2000-2012.
12. Wu, Y.; Mao, F.; Zuo, X.; Moussalli, M. J.; Elias, E.; Xu, W.; Shureiqi, I. Cancer Med. 2014, 3, 472-484.
13. Palani, A.; Shapiro, S.; Clader, J. W.; Greenlee, W. J.; Vice, S.; McCombie, S.; Cox, K.; Strizki, J.; Baroudy, B. M. Bioorg. Med. Chem. Lett. 2003, 13, 709-712.
14. Nezhawy, A. O. H. E.; Radwan, M. A. A.; Gaballah, S. T. Arkivoc 2009, 12, 119-130.
15. Sati, N.; Kumar, S.; Rawat, M. S. M. Ind. J. Chem. 2012, 51B, 318-322.
16. Cocco, M. T.; Congiu, C.; Onnis, V.; Morelli, M.; Cauli, O. Eur. J. Med. Chem. 2003, 38, 513-518.
17. Moffet, R. B.; Rober, A.; Skaletzky, L. L. J. Med. Chem. 1971, 14, 963-968.
18. Siddiqui, N.; Alam, M. S; Ahsan, W. Acta Pharma. 2008, 58, 445-454.
19. Hussein, A. H. M.; Gad-Elkareem, M. A. M.; El-Adasy, A. A. A. M.; Othman, I. M. Phosphorus Sulfur Silicon Relat. Elem. 2009, 184, 2263-2280.
20. Salem, M. A.; Thabet, H. K. H.; Helal, M. H.; Abdelaal, A. S.; Ammar, Y. A. Chem. Sci. J. 2011, 32, 1-12.
21. Khalid, H.; Aziz-ur-Rehman; Abbasi, M. A.; Khan, K. M.; Ashraf, M.; Ahmad, I.; Ejaz, S. A. Pak. J. Pharm. Sci. 2013, 26, 479-485.
22. Prashanth, M. K.; Revanasiddappa, H. D.; Lokanatha, K. M.; Veeresh, R. B. Bioorg. Med. Chem. Lett. 2012, 22, 7065-7070.
23. Elavarasan, T.; Bhakiaraj, D. P.; Gopalakrishnan, M. ISRN Organic Chemistry 2014, 2014, 120173.
24. Hansch, C.; Sammes, P. G.; Taylor, J. B. Comprehensive Medicinal Chemistry; Pergamon Press: Oxford, UK, 1990.
25. Stokes, S. S.; Albert, R.; Buurman, E. T.; Andrews, B.; Shapiro, A. B.; Green, O. M.; McKenzie, A. R.; Otterbein, L. R. Bioorg. Med. Chem. Lett. 2012, 22, 7019-7023.
26. Karabasanagouda, T.; Adhikari, A. V.; Shetty, N. S. Eur. J. Med. Chem. 2007, 42, 521-529.
27. Chawla, G.; Kumar, U.; Bawa, S.; Kumar, J. J. Enzy. Inhib. Med. Chem. 2012, 27, 658-665.
28. Ibrahim, D. A. Eur. J. Med. Chem. 2009, 44, 2776-2781.
29. Kritsanida, M.; Mouroutsou, A.; Marakos, P.; Pouli, N.; Papakonstantinou-Garoufalias, S.; Pannecouque, C.; Witvrouw, M.; De-Clercq, E. Farmaco 2002, 57, 253-257.
30. Barbe, V.; Cruveiller, S.; Kunst, F.; Lenoble, P.; Meurice, G.; Sekowska, A.; Vallenet, D.; Wang, T.; Moszer, I.; Medigue, C. et al. Microbiology 2009, 155, 1758-1775.
31. Harris, L. G.; Foster, S. J.; Richards, R. G. Eur. Cells Mater. 2002, 4, 39-60.
32. Bhattacharya, S. S.; Das, U.; Choudhury, B. K. Indian J. Med. Res. 2011, 133, 431-433.
33. Vogt, R. L.; Dippold, L. Public Health Rep. 2005, 120, 174-178.
34. Pressler, T.; Bohmova, C.; Conway, S.; Dumcius, S.; Hjelte, L.; Hoiby, N.; Kollberg, H.; T¨ummler, B.; Vavrova, V. J. Cyst. Fibros. 2011, 10, 75-78.
35. Jorgensen, W. L. Science 2004, 303, 1813-1818.
36. Bajorath, J. Nat. Rev. Drug Discov. 2002, 1, 882-894.
37. Langer, T.; Hoffmann, R. D. Curr. Pharm. Des. 2001, 7, 509-527.
38. Kitchen, D. B.; Decornez, H.; Furr, J. R.; Bajorath, J. Nat. Rev. Drug Discov. 2004, 3, 935-949.
39. Gohlke, H.; Klebe, G. Angew. Chem. Int. Ed. Engl. 2002, 41, 2644-2676.
40. Khalid, H.; Aziz-ur-Rehman; Abbasi, M. A.; Malik, A.; Rasool, S.; Nafeesa, K.; Ahmad, I.; Afzal, S. J. Saudi Chem. Soc. 2016, 20, S615-S623.
41. Kaspady, M.; Narayanaswamy, V. K.; Raju, M.; Rao, G. K. Lett. Drug Des. Discov. 2009, 6, 21-28.
42. Baylac, S.; Racine, P. Int. J. Aromather. 2003, 13, 138-142.
43. Bostro, M. J.; Greenwood, J. R.; Gottfries, J. Mol. Graph. Model. 2003, 21, 449-462.